|
This year, China's economic operation for the outstanding contradictions and problems, the central introduced a series of macro-control policies and measures, the national economy maintained steady and rapid development. In the first half, GDP grew by 11.50% over the previous year increased by 0.5 percentage points over the same period, showing a growth rate of the economy run faster, improve quality and efficiency, the structure became more balanced development trend. By the State increasingly positive impact the overall macroeconomic environment, medicine and the general run of economic growth showed industrial production, commercial purchase and sales growth momentum of stable and effective level of improvement in the good development pattern. To maintain stable and rapid development momentum This year, pharmaceutical companies around the reform and development closely around the two main goals of accelerating institutional innovation, technological innovation and management innovation, accelerate the pace of reform and restructuring of property rights system. The role of the market adjustment mechanism to further enhance and promote the competitiveness of production and operations continue to improve and promote the improvement of economic efficiency of enterprises, the pharmaceutical industry's contribution to macroeconomic growth and further improve. According to statistics, from 1998 to 2006 8 years, the pharmaceutical industry average sales revenue increased 18%; profit on an annual average of about 20%; chemical raw materials, production exceeded 1 million tons; proprietary production multiplied; import and export of pharmaceutical products topped 10 billion U.S. dollars; domestic pharmaceutical market average growth rate of 15%. Technological innovation to bring the product structure optimization, with the "creative combination of imitation" strategy implementation, technology features and brand name brand drugs more and more Chinese brands, especially great potential. M & A Medicine circulation is still a bright spot With the trend of global economic integration the strengthening of the increasingly fierce market competition, macroeconomic regulation and control from outside the industry, trade reform and development within the objective requirements of both the medical and speed the pace of industry consolidation. Mergers and acquisitions, restructuring changed the map of the pharmaceutical market, and gradually perfect the pharmaceutical industry chain. Its characteristics are: First, the trend of state-owned Shares obvious; second into the pharmaceutical industry, the capital outstanding; Third, private capital into state-owned enterprises is a merger, reorganization highlights. A number of strong companies have accelerated the pace of mergers and acquisitions to become a regional leading enterprises, promote the restructuring of pharmaceutical distribution system and operation of the modernization process; accelerated the circulation of Traditional Chinese Medicine to scale and intensive development of improved market share, control and economic benefits. In addition, because the field of pharmaceutical distribution services to further open up, encourage foreign investment with strong capital strength, advanced management concepts, scientific management methods, modern tools, a complete supply system, the objectives of cooperation focus in the pharmaceutical distribution former top ten enterprises. Scale industry Intensive feature highlights According to Chinese medicine Chinese Business Association, 2006 National Survey of basic business corporate information, access to hundred businesses bottom line from the 2005 sales volume of 529 million yuan raised to 580 million yuan. In the hundred enterprises, more than 10 billion yuan sales volume are three; more than 5 billion yuan were 9; over 30 billion yuan, 15; than 20 billion yuan and 27; more than 1 billion yuan were 55, than substantial increase over the previous year, of which the top three companies in the pharmaceutical market in the country's total sales volume proportion of 18.95% over the previous year increase of 1.25 percentage points. According to statistics, in 2006 the pharmaceutical industry sales and profits of the province's top 10 percentage of the total 70% of the industry. 500 key enterprises of Chinese business (annual sales of 50 million yuan or above), merchandise sales, net income of 217.174 billion yuan, accounting for 85.98 percent the industry, increase its share of 1.18 percentage points over the previous year, of which the top 10 enterprises Total sales revenue was 60.596 billion yuan, accounting for 24% of the industry, accounting for 28% of key enterprises. Focus on corporate profits amounted to 2.68 billion yuan, total profit of the top 10 of which 9.65 billion yuan, accounting for 41.10 percent of industrial profits, accounting for 36% of key enterprises. This year, the industry is more prominent advantage of economies of scale, concentration of market and economic concentration was further increased. I am an expert from womenleatherbackpacks.com, while we provides the quality product, such as backpacks for laptops , leather purse backpacks Manufacturer, briefcases on wheels,and more.
Related Articles -
backpacks for laptops, leather purse backpacks Manufacturer,
|
